Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

Abstract Background β-adrenergic antagonists (BAAs) are used to treat cardiovascular disease such as ischemic heart disease, congestive heart failure, dysrhythmias, and hypertension. Poisoning from BAAs can lead to severe morbidity and mortality. We aimed to determine the utility of extracorporeal t...

Full description

Bibliographic Details
Main Authors: Josée Bouchard, Greene Shepherd, Robert S. Hoffman, Sophie Gosselin, Darren M. Roberts, Yi Li, Thomas D. Nolin, Valéry Lavergne, Marc Ghannoum, the EXTRIP workgroup
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-021-03585-7